PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
29-May-2024 Broughton receives Schedule 1 controlled drugs licence Broughton
28-May-2024 Omnia Technologies acquires ACMI, SACMI Beverage and SACMI Labelling to create a leading provider of turnkey high-speed beverage automation solutions Omnia Technologies
28-May-2024 STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024 STORM Therapeutics Ltd
28-May-2024 First patients in Spain to be treated with Pepaxti Oncopeptides AB
28-May-2024 Medigene AG Expands its End-to-End Platform by Submitting Three Patents to the European Patent Office Medigene AG
28-May-2024 TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024 TILT Biotherapeutics (TILT)
28-May-2024 Press Release: Thermo Fisher Scientific launches ‘Make in India’ Air Quality Monitoring Systems to support India’s clean air initiatives Thermo Fisher
28-May-2024 Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe Celltrion
28-May-2024 Bio-Sourcing, Ciloa and Intract Pharma launch €3.4M EU project in inflammatory indications with €1.9M subsidies from EUREKA Eurostars Andrew Lloyd Associates
28-May-2024 Protheragen-ING Lab, a Trustworthy GLP Service Provider, Unveils Its Cutting-Edge Medical Device Services Protheragen-ING Lab
28-May-2024 Alfa Chemistry Optimizes Its Microalgae Powder and Related Natural Extract Production Service Alfa Chemistry
28-May-2024 Alfa Chemistry Enriches Product Portfolio with Adsorbent, Mixed Bed, Chelating, and Catalyst Resins for Ion-Exchange Scenarios Alfa Chemistry
27-May-2024 Ace Therapeutics Expands Parasitology Research Capabilities by Introducing Parasite Testing Platform Ace Therapeutics
27-May-2024 Creative Proteomics Introduces Advanced GST Pull-Down Service for Protein Interaction Studies Creative Proteomics
24-May-2024 SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford SpyBiotech
23-May-2024 Global oncology trial investigator sites increase by half in five years, finds new Phesi analysis Phesi
23-May-2024 Grey Wolf Therapeutics Closes Oversubscribed $50 Million Series B Financing Expansion, Led by ICG Life Sciences, to Accelerate and Expand First-of-its-Kind Antigen Modulation Technology Grey Wolf Therapeutics
23-May-2024 Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 Conference Pneumagen
23-May-2024 Rare genetic diseases and genomics: past, present and future – public lecture by Professor Eamonn Maher Aston Medical School
23-May-2024 SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford SpyBiotech